Organon (OGN) Tops Q2 EPS by 30c

Organon (NYSE: OGN) reported Q2 EPS of $1.72, $0.30 better than the analyst estimate of $1.42. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.52 billion.

GUIDANCE:

Organon sees FY2021 revenue of $6.1-6.4 billion, versus the consensus of $6.25 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Organon gets FDA approval for expanded TOFIDENCE uses
• Limoneira (LMNR) Misses Q2 EPS by 8c, Beats on Revenue